A Novel Anti-Apoptosis Serum Factor That Down-Regulates Fas-Mediated Apoptosis^1
スポンサーリンク
概要
- 論文の詳細を見る
- 1995-05-01
著者
-
KIKUCHI Hiroshi
Pharmaceutical Formulation Research Laboratory, Daiichi Pharmaceutical Co., Ltd.
-
IMAJOH-OHMI Shinobu
Institute of Medical Science, Tokyo University
-
Kikuchi H
Pharmaceutical Formulation Research Laboratory Daiichi Pharmaceutical Co. Ltd.
-
Imajoh-ohmi Shinobu
Institute Of Medical Science The University Of Tokyo
-
KIKUCHI Hidehiko
Institute of Medical Science, The University of Tokyo
-
SUGIYAMA Shinji
Institute of Medical Science, The University of Tokyo
-
Sugiyama Shinji
Institute Of Medical Science The University Of Tokyo
-
Kikuchi Hidehiko
Institute Of Medical Science University Of Tokyo
関連論文
- PU.1 Is Dominant and HAF-1 Supplementary for Activation of the gp91^ Promoter in Human Monocytic PLB-985 Cells^1
- Phorbol Ester-Potentiated Liposomal Transfection to Monocytic PLB-985 Cells^1
- Importance of 2-O-Sulfate Groups of Uronate Residues in Heparin for Activation of FGF-1 and FGF-2
- Calpain-μ is activated in hepatocyte mitochondria during ischemia-reperfusion injury
- Importance of 6-O-Sulfate Groups of Glucosamine Residues in Heparin for Activation of FGF-1 and FGF-2
- A Novel Anti-Apoptosis Serum Factor That Down-Regulates Fas-Mediated Apoptosis^1
- Cross-linking of B cell antigen receptorrelated structure of pre-B cell lines induces tyrosine phosphorylation of p85 and p110 subunits and activation of phosphatidylinositol 3-kinase
- Caspases Cleave the Amino-Terminal Calpain Inhibitory Unit of Calpastatin during Apoptosis in Human Jurkat T Cells^1
- PU.1 Is Dominant and HAF-1 Supplementary for Activation of the gp91phox Promoter in Human Monocytic PLB-985 Cells.